 |
|
Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population
Jonna Perälä, MD;
Jaana Suvisaari, MD, PhD;
Samuli I. Saarni, MD, MSocSc;
Kimmo Kuoppasalmi, MD, PhD;
Erkki Isometsä, MD, PhD;
Sami Pirkola, MD, PhD;
Timo Partonen, MD, PhD;
Annamari Tuulio-Henriksson, PhD;
Jukka Hintikka, MD, PhD;
Tuula Kieseppä, MD, PhD;
Tommi Härkänen, PhD;
Seppo Koskinen, MD, PhD;
Jouko Lönnqvist, MD, PhD
Arch Gen Psychiatry. 2007;64(1):19-28.
Context Recent general population surveys of psychotic disorders have found low lifetime prevalences. However, this may be owing to methodological problems. Few studies have reported the prevalences of all specific psychotic disorders.
Objective To provide reliable estimates of the lifetime prevalences of specific psychotic disorders.
Design General population survey.
Setting and Participants A nationally representative sample of 8028 persons 30 years or older was screened for psychotic and bipolar I disorders using the Composite International Diagnostic Interview, self-reported diagnoses, medical examination, and national registers. Those selected by the screens were then reinterviewed with the Structured Clinical Interview for DSM-IV. Best-estimate DSM-IV diagnoses were formed by combining the interview and case note data. Register diagnoses were used to estimate the effect of the nonresponders.
Main Outcome Measures Diagnosis of any psychotic or bipolar I disorder according to the DSM-IV criteria.
Results The lifetime prevalence of all psychotic disorders was 3.06% and rose to 3.48% when register diagnoses of the nonresponder group were included. Lifetime prevalences were as follows: 0.87% for schizophrenia, 0.32% for schizoaffective disorder, 0.07% for schizophreniform disorder, 0.18% for delusional disorder, 0.24% for bipolar I disorder, 0.35% for major depressive disorder with psychotic features, 0.42% for substance-induced psychotic disorders, and 0.21% for psychotic disorders due to a general medical condition. The National Hospital Discharge Register was the most reliable of the screens ( = 0.80). Case notes supplementing the interviews were essential for specific diagnoses of psychotic disorders.
Conclusions Multiple sources of information are essential for accurate estimation of lifetime prevalences of psychotic disorders. The use of comprehensive methods reveals that their lifetime prevalence exceeds 3%.
Author Affiliations: Departments of Mental Health and Alcohol Research (Drs Perälä, Suvisaari, Saarni, Kuoppasalmi, Isometsä, Pirkola, Partonen, Tuulio-Henriksson, Hintikka, Kieseppä, and Lönnqvist) and Health and Functional Capacity (Drs Härkänen and Koskinen), National Public Health Institute, Department of Psychiatry, University of Helsinki (Drs Isometsä, Kieseppä, and Lönnqvist), and Health and Social Services Division, National Research and Development Centre for Welfare and Health (Dr Pirkola), Helsinki, Finland; Tampere School of Public Health, University of Tampere (Dr Suvisaari), and Department of Psychiatry, Tampere University Hospital (Dr Hintikka), Tampere, Finland; and Department of Psychiatry, Päijät-Häme Central Hospital, Lahti, Finland (Dr Hintikka).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLE
The Surprisingly Rich Contours of Schizophrenia Epidemiology
John J. McGrath
Arch Gen Psychiatry. 2007;64(1):14-16.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Subjective Experience of Cognitive Failures as Possible Risk Factor for Negative Symptoms of Psychosis in the General Population
Pfeifer et al.
Schizophr Bull 2009;35:766-774.
ABSTRACT
| FULL TEXT
Evidence That Onset of Clinical Psychosis Is an Outcome of Progressively More Persistent Subclinical Psychotic Experiences: An 8-Year Cohort Study
Dominguez et al.
Schizophr Bull 2009;0:sbp022v1-sbp022.
ABSTRACT
| FULL TEXT
Development and implementation of early intervention services for young people with psychosis: case study
Lester et al.
Br. J. Psychiatry 2009;194:446-450.
ABSTRACT
| FULL TEXT
Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
Koskinen et al.
Schizophr Bull 2009;0:sbp031v1-sbp031.
ABSTRACT
| FULL TEXT
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated
Marrie et al.
Mult Scler 2009;15:385-392.
ABSTRACT
A salience dysregulation syndrome
van Os
Br. J. Psychiatry 2009;194:101-103.
ABSTRACT
| FULL TEXT
Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment
Haussleiter et al.
Therapeutic Advances in Neurological Disorders 2009;2:13-29.
ABSTRACT
Childhood IQ and Adult Mental Disorders: A Test of the Cognitive Reserve Hypothesis
Koenen et al.
Am. J. Psychiatry 2009;166:50-57.
ABSTRACT
| FULL TEXT
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath et al.
Epidemiol Rev 2008;30:67-76.
ABSTRACT
| FULL TEXT
Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study
Morgan et al.
Br. J. Psychiatry 2008;193:364-372.
ABSTRACT
| FULL TEXT
Clinical questions and uncertainty -- prolactin measurement in patients with schizophrenia and bipolar disorder
Walters and Jones
J Psychopharmacol 2008;22:82-89.
ABSTRACT
Authors' reply
Baca-Garcia et al.
Br. J. Psychiatry 2007;191:265-266.
FULL TEXT
Lifetime prevalence of psychotic disorders in Finland is 3.1%
Altindag
Evid. Based Ment. Health 2007;10:96-96.
FULL TEXT
Differentiation in the Preonset Phases of Schizophrenia and Mood Disorders: Evidence in Support of a Bipolar Mania Prodrome
Correll et al.
Schizophr Bull 2007;0:sbm028v1-1.
ABSTRACT
| FULL TEXT
The Surprisingly Rich Contours of Schizophrenia Epidemiology
McGrath
Arch Gen Psychiatry 2007;64:14-16.
FULL TEXT
|
